A trial in the timing of surgery and adjuvant chemotherapy for hepatic metastases from colorectal cancer.

 

Trial Summary:

A phase III, multicentre randomised trial comparing perioperative morbidity in patients given chemotherapy before and after surgical resection and those given chemotherapy after surgical resection.

Supported By:

Cancer Australia

Eligibility:

Patients with metastatic colorectal cancer with resectable liver metastases

Registration ID:

ACTRN12610000647033

Participation:

Local

Australian Lead Group:

AGITG

Status:

closed

Activation Date:

12/08/2011

Chairs:

Jonathan Fawcett (Australia), David Goldstein (Australia)

Contact:

attache@ctc.usyd.edu.au